A Phase 2 Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Cardiac and Renal Effects of Short Term Treatment with Elamipretide in Patients Hospitalized with Congestion due to Heart Failure

Trial Profile

A Phase 2 Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Cardiac and Renal Effects of Short Term Treatment with Elamipretide in Patients Hospitalized with Congestion due to Heart Failure

Recruiting
Phase of Trial: Phase II

Latest Information Update: 18 Jan 2018

At a glance

  • Drugs Elamipretide (Primary)
  • Indications Heart failure
  • Focus Therapeutic Use
  • Acronyms IDDEA-HF
  • Sponsors Stealth BioTherapeutics
  • Most Recent Events

    • 18 Jan 2018 This study has been completed in Hungary (End Date:2017-12-27)
    • 12 Jan 2018 This study has been completed in latvia(on 2017-12-27) as per European Clinical Trials Database.
    • 10 Jan 2018 This study has been completed in Bulgaria as per European Clinical Trials Database
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top